会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • NEUROPEPTIDE Y ANALOGS
    • 神经元Y模拟
    • WO2007039318A3
    • 2007-07-05
    • PCT/EP2006009812
    • 2006-10-05
    • SCHERING AGSRINIVASAN ANANTH
    • SRINIVASAN ANANTH
    • C07K14/575A61K38/22G01N33/68
    • C07K14/57545
    • The neuropeptideY (NPY) -receptor-subtype Yl is expressed differentially from breast tumor cells and is therefore an advantageous target molecule for the molecular imaging of breast cancer. Peptide analogs were synthesized, whose sequence is reduced to the receptor-binding sections of the natural ligand NPY. These Yl receptor-selective peptide analogs contain unnatural amino acids that increase the receptor affinity and are to ensure the stability of the greatly shortened peptide. New NPY analogs, which are to be used as radioligands, were tested for their binding affinity and selectivity for the Yl receptor.
    • 神经肽Y(NPY)受体亚型Y1与乳腺肿瘤细胞差异表达,因此是乳腺癌分子成像的有利靶分子。 合成肽类似物,其序列被还原成天然配体NPY的受体结合部分。 这些Y1受体选择性肽类似物含有增加受体亲和力的非天然氨基酸,并且确保大大缩短的肽的稳定性。 测试用作放射性配体的新NPY类似物对Y1受体的结合亲和力和选择性。